Gene · 9507
NIH grants1,059
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 1,059
Download this page as JSON| Grant | Title | ADAMTS4 papers | Newest fiscal year |
|---|---|---|---|
| R01AR074096 | Monitoring Disease in Lupus | 1 | 2025 |
| R01AR078917 | Understanding the mechanisms by which weight change affects progression of knee osteoarthritis in obese and overweight individuals: An analysis of the Osteoarthritis Initiative Dataset | 1 | 2025 |
| R01CA269919 | Comprehensive identification of germline-somatic interactions | 1 | 2025 |
| R01DE025225 | Treponema - Host Cell and Tissue Interactions | 1 | 2025 |
| R01DK123028 | Mechanisms of human adipose tissue development and impact of diabetes | 1 | 2025 |
| R01DK125465 | The Immune Response After Drug Induced Hepatotoxicity | 1 | 2025 |
| R01DK132888 | The Role of Vascular Calprotectin in Arteriovenous Fistula Maturation | 1 | 2025 |
| R01EY020866 | Unfolded Protein Response in Drosophila models of Retinitis Pigmentosa | 1 | 2025 |
| R01EY020894 | Targeting Tissue Biomechanics for Treatment of Glaucoma | 1 | 2025 |
| R01EY022359 | eNOS-Dependent Mechanoregulation of Intraocular Pressure | 1 | 2025 |
| R01EY030238 | The Aqueous Humor Outflow Resistance | 1 | 2025 |
| R01EY030501 | Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye | 1 | 2025 |
| R01EY032905 | NFAT and fibrosis in the trabecular meshwork | 1 | 2025 |
| R01GM127791 | Targeting ACOD1 to attenuate innate immune responses to lethal infections | 1 | 2025 |
| R01HD020676 | Trophoblast Differentiation | 1 | 2025 |
| R01HL080396 | Role of mucin in lung homeostasis and pathophysiology | 1 | 2025 |
| R01HL121877 | Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis | 1 | 2025 |
| R01HL127349 | Genomic Analysis of Tissue and Cellular Heterogeneity in IPF | 1 | 2025 |
| R01HL131652 | Defining the Mechanisms of Lymphatic Vascular Growth and Function | 1 | 2025 |
| R01HL133120 | Molecular and Cellular Mechanisms in Coronary Artery Development and Anomalies | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/grants?page=5